Brooks BR - Search Results

1

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. Brooks BR, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9. doi: 10.1080/146608200300079536. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000. PMID: 11464847 Review. No abstract available.

2

Intravenous thyrotropin releasing hormone in amyotrophic lateral sclerosis: autonomic effects.

Beaulieu DA, Erickson L, Williams A, Sufit RL, Brooks BR. Beaulieu DA, et al. Among authors: brooks br. Neurol Clin. 1987 May;5(2):269-90, vi. Neurol Clin. 1987. PMID: 11681403

3

Role of muscular exercise in amyotrophic lateral sclerosis.

Sanjak M, Reddan W, Brooks BR. Sanjak M, et al. Among authors: brooks br. Neurol Clin. 1987 May;5(2):251-68, vi. Neurol Clin. 1987. PMID: 11681402 Review.

4

Natural history of amyotrophic lateral sclerosis. Quantification of symptoms, signs, strength, and function.

Brooks BR, Shodis KA, Lewis DH, Rawling JD, Sanjak M, Belden DS, Hakim H, DeTan Y, Gaffney JM. Brooks BR, et al. Adv Neurol. 1995;68:163-84. Adv Neurol. 1995. PMID: 8787228 Review. No abstract available.

5

Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis.

Sanjak M, Konopacki R, Capasso R, Roelke KA, Peper SM, Houdek AM, Waclawik A, Brooks BR. Sanjak M, et al. Among authors: brooks br. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Mar;5(1):26-32. doi: 10.1080/14660820310017551. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15204021

6

Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.

Sanjak M, Brinkmann J, Belden DS, Roelke K, Waclawik A, Neville HE, Ringel SP, Murphy JR, Brooks BR. Sanjak M, et al. Among authors: brooks br. J Neurol Sci. 2001 Oct 15;191(1-2):55-9. doi: 10.1016/s0022-510x(01)00624-4. J Neurol Sci. 2001. PMID: 11676992 Clinical Trial.

7

Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists.

Brooks BR, Juhasz-Poscine K, Waclawik A, Sanjak M, Belden D, Roelke K, Parnell J, Weasler C. Brooks BR, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1 Suppl 4:45-53; discussion 53-4. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000. PMID: 11466959 Review. No abstract available.

8

Functional magnetic resonance imaging (fMRI) clinical studies in ALS--paradigms, problems and promises.

Brooks BR, Bushara K, Khan A, Hershberger J, Wheat JO, Belden D, Henningsen H. Brooks BR, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Jun;1 Suppl 2:S23-32. doi: 10.1080/14660820052415790. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000. PMID: 11464937 Review.

9

Risk factors in the early diagnosis of ALS: North American epidemiological studies. ALS CARE Study Group.

Brooks BR. Brooks BR. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S19-26. doi: 10.1080/14660820052415871. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000. PMID: 11464921

10

Earlier is better: the benefits of early diagnosis.

Brooks BR. Brooks BR. Neurology. 1999;53(8 Suppl 5):S53-4; discussion S55-7. Neurology. 1999. PMID: 10560640 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results